The future of drug safety - lessons learned from the usa and implications for the global south
- At: 2009 FIP Congress in Istanbul (Turkey)
- Type: Presentation
- By: STERGACHIS, Andy (University of Washington, Seattle, United States of America)
Pharmacovigilance is critical to evaluating a medicine's risk-benefit profile over a product's life-cycle and guide the best use of medicines. In 2005, the US Institute of Medicine was asked to examine the system of drug safety in the US. This assessment resulted in a series of far-reaching recommendations intended to improve the system of drug.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.